MARATTO

article · Naunyn-Schmiedeberg s Archives of Pharmacology

Alogliptin repositioning confers protection against diclofenac-induced liver injury by inhibiting TLR4/NF-κB, ROS/TXNIP, and NLRP3 inflammasome-mediated pyroptosis in rats

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

  • Drug-Induced Hepatotoxicity and Protection
  • Inflammasome and immune disorders
  • Inflammatory mediators and NSAID effects

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1007/s00210-025-04666-y

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.